RA patients exhibit a decrease in the percentage of IL-10-producing B cells (12, 13), and RA patients with active disease have fewer transitional CD19+CD24hiCD38hi B cells, described as IL-10+ regulatory cells, in peripheral blood than patients with inactive disease or healthy individuals (14). The gene discussed is CD19; the disease is rheumatoid arthritis.